104 related articles for article (PubMed ID: 16806063)
1. Design and characterization of a novel cellular prion-derived quenched fluorimetric substrate of alpha-secretase.
Cissé MA; Gandreuil C; Hernandez JF; Martinez J; Checler F; Vincent B
Biochem Biophys Res Commun; 2006 Aug; 347(1):254-60. PubMed ID: 16806063
[TBL] [Abstract][Full Text] [Related]
2. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity.
Cissé MA; Sunyach C; Lefranc-Jullien S; Postina R; Vincent B; Checler F
J Biol Chem; 2005 Dec; 280(49):40624-31. PubMed ID: 16236709
[TBL] [Abstract][Full Text] [Related]
3. Isoform-specific contribution of protein kinase C to prion processing.
Alfa Cissé M; Louis K; Braun U; Mari B; Leitges M; Slack BE; Fisher A; Auberger P; Checler F; Vincent B
Mol Cell Neurosci; 2008 Nov; 39(3):400-10. PubMed ID: 18722532
[TBL] [Abstract][Full Text] [Related]
4. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein.
Vincent B; Paitel E; Saftig P; Frobert Y; Hartmann D; De Strooper B; Grassi J; Lopez-Perez E; Checler F
J Biol Chem; 2001 Oct; 276(41):37743-6. PubMed ID: 11477090
[TBL] [Abstract][Full Text] [Related]
5. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
[TBL] [Abstract][Full Text] [Related]
6. Chronic hypoxia in the human neuroblastoma SH-SY5Y causes reduced expression of the putative alpha-secretases, ADAM10 and TACE, without altering their mRNA levels.
Marshall AJ; Rattray M; Vaughan PF
Brain Res; 2006 Jul; 1099(1):18-24. PubMed ID: 16762326
[TBL] [Abstract][Full Text] [Related]
7. M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity.
Alfa Cissé M; Sunyach C; Slack BE; Fisher A; Vincent B; Checler F
J Neurosci; 2007 Apr; 27(15):4083-92. PubMed ID: 17428986
[TBL] [Abstract][Full Text] [Related]
8. Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase.
Asai M; Hattori C; Szabó B; Sasagawa N; Maruyama K; Tanuma S; Ishiura S
Biochem Biophys Res Commun; 2003 Jan; 301(1):231-5. PubMed ID: 12535668
[TBL] [Abstract][Full Text] [Related]
9. Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metalloproteinases.
Endres K; Postina R; Schroeder A; Mueller U; Fahrenholz F
FEBS J; 2005 Nov; 272(22):5808-20. PubMed ID: 16279945
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal cleavage of cellular prion protein in the human brain.
Laffont-Proust I; Faucheux BA; Hässig R; Sazdovitch V; Simon S; Grassi J; Hauw JJ; Moya KL; Haïk S
FEBS Lett; 2005 Nov; 579(28):6333-7. PubMed ID: 16263114
[TBL] [Abstract][Full Text] [Related]
11. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.
McDonald AJ; Dibble JP; Evans EG; Millhauser GL
J Biol Chem; 2014 Jan; 289(2):803-13. PubMed ID: 24247244
[TBL] [Abstract][Full Text] [Related]
12. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.
Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K
Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880
[TBL] [Abstract][Full Text] [Related]
13. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
14. The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein.
Allinson TM; Parkin ET; Condon TP; Schwager SL; Sturrock ED; Turner AJ; Hooper NM
Eur J Biochem; 2004 Jun; 271(12):2539-47. PubMed ID: 15182369
[TBL] [Abstract][Full Text] [Related]
15. ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein.
Moss ML; Powell G; Miller MA; Edwards L; Qi B; Sang QX; De Strooper B; Tesseur I; Lichtenthaler SF; Taverna M; Zhong JL; Dingwall C; Ferdous T; Schlomann U; Zhou P; Griffith LG; Lauffenburger DA; Petrovich R; Bartsch JW
J Biol Chem; 2011 Nov; 286(47):40443-51. PubMed ID: 21956108
[TBL] [Abstract][Full Text] [Related]
16. The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.
Cissé M; Duplan E; Guillot-Sestier MV; Rumigny J; Bauer C; Pagès G; Orzechowski HD; Slack BE; Checler F; Vincent B
J Biol Chem; 2011 Aug; 286(33):29192-29206. PubMed ID: 21586567
[TBL] [Abstract][Full Text] [Related]
17. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion.
Hundhausen C; Misztela D; Berkhout TA; Broadway N; Saftig P; Reiss K; Hartmann D; Fahrenholz F; Postina R; Matthews V; Kallen KJ; Rose-John S; Ludwig A
Blood; 2003 Aug; 102(4):1186-95. PubMed ID: 12714508
[TBL] [Abstract][Full Text] [Related]
18. The sheddase ADAM10 is a potent modulator of prion disease.
Altmeppen HC; Prox J; Krasemann S; Puig B; Kruszewski K; Dohler F; Bernreuther C; Hoxha A; Linsenmeier L; Sikorska B; Liberski PP; Bartsch U; Saftig P; Glatzel M
Elife; 2015 Feb; 4():. PubMed ID: 25654651
[TBL] [Abstract][Full Text] [Related]
19. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.
Bozkulak EC; Weinmaster G
Mol Cell Biol; 2009 Nov; 29(21):5679-95. PubMed ID: 19704010
[TBL] [Abstract][Full Text] [Related]
20. Changes in expressions of ADAM9, 10, and 17 as well as α-secretase activity in renal cell carcinoma.
Erin N; İpekçi T; Akkaya B; Özbudak İH; Baykara M
Urol Oncol; 2017 Jan; 35(1):36.e15-36.e22. PubMed ID: 27692848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
